Are cannabis products safe and effective for reducing symptoms in children with cancer?

Analysis finds insufficient data from published studies

2023-08-28

(Press-News.org) A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer. The analysis is published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

Although treatments for childhood cancer have improved significantly, even leading to cures for many patients, many children still suffer from symptoms such as pain, anxiety, and weight loss related to cancer and its treatment. Over the last decade, cannabis products—both synthetic cannabinoids and natural phytocannabinoids—have gained popularity with patients and families for managing such symptoms, but pediatric oncologists are cautious to authorize cannabis for their patients given the limited data to inform dosing, product selection, and safety monitoring.

To provide insights for clinicians and parents, and to inform an upcoming clinical trial, a team led by Lauren E. Kelly, PhD, associate professor of pharmacology and therapeutics in the Rady Faculty of Health Sciences at the University of Manitoba, searched the medical literature to summarize existing knowledge about the potential benefits and harms of cannabis products in children with cancer.

The investigators identified 19 unique studies with a total of 1,927 participants with cancer: eight retrospective chart reviews, seven randomized controlled trials, two open‐label studies, and two case reports. The products studied included medical-grade cannabinoids (such as the prescription drug nabilone), synthetic cannabinoids, and unspecified cannabis herbal extracts. Products were most commonly used to manage chemotherapy‐induced nausea and vomiting.

In the randomized controlled trials, patients who used cannabinoids were more likely to experience drowsiness, feeling high, dizziness, and dry mouth. Also, trial participants who received cannabinoids were almost four times more likely to drop from the study due to adverse events, compared with the control group who received placebo. Across all included studies, no serious cannabis‐related adverse events were reported.

Dr. Kelly and her colleagues noted that most studies did not adequately describe the types, dosing, frequencies, and routes of administration of cannabis products, and outcomes were mixed and were reported in different ways. Therefore, researchers should develop standards for reporting cannabis exposures, cannabis‐related effects, and patient outcomes.

“It was difficult to measure benefit across studies, given a range of different outcomes and study designs; however, in interventional studies with active control groups, cannabinoids performed better in managing nausea and vomiting. Data are lacking on cannabinoids’ effects on pain, mood, sleep, and health-related quality of life,” said Dr. Kelly. “Given that some children report benefits and some children experience adverse events, it is critical that more rigorous studies evaluating the effects of cannabinoids on children with cancer are conducted and shared with parents, patients, and the health care community.”

This literature review informed the design of CANnabinoids in Pediatric ONCology (CAN-PONC), which will begin recruiting 60 patients into a three-arm tolerability trial later this winter. The literature review and clinical trial are part of a team grant funded by the Canadian Cancer Society and Canadian Institutes of Health Research through a Cannabis Team Grant.

Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.

Full Citation:
“Cannabinoids for symptom management in children with cancer: A systematic review and meta‐analysis.” Manik Chhabra, Mohamed Ben‐Eltriki, Arun Paul, Mê‐Linh Lê, Anthony Herbert, Sapna Oberoi, Natalie Bradford, Alison Bowers, S. Rod Rassekh, and Lauren E. Kelly. CANCER; Published Online: August 28, 2023 (DOI: 10.1002/cncr.34920).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.34920

Author Contact: Ilana Simon, Director of Communications & Marketing, Rady Faculty of Health Sciences, University of Manitoba, ilana.simon@umanitoba.ca

About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on Twitter @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.

About Wiley
Wiley is a knowledge company and a global leader in research, publishing, and knowledge solutions. Dedicated to the creation and application of knowledge, Wiley serves the world’s researchers, learners, innovators, and leaders, helping them achieve their goals and solve the world's most important challenges. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.

END

ELSE PRESS RELEASES FROM THIS DATE:

First defence against devastating ToCSV tomato virus explored

2023-08-28

How tomato plants defend themselves against a devastating ‘young’ Southern African virus has now been investigated at a molecular genetics level for the first time by researchers at the University of Johannesburg (UJ). The Ty-1 gene is known to confer resistance to the well-known tomato yellow leaf curl virus (TYLCV). UJ researchers investigated what happens when tomato plants that harbour the Ty-1 gene are infected with the relatively unknown tomato curly stunt virus (ToCSV). They found a link between tolerance to ToCSV, a plant defence called viral DNA methylation, and Ty-1 gene activity. The research is published ...

Sleep can be most restful for older adults when nighttime temperature range is between 68 to 77 °F, study finds

2023-08-28

New research finds that sleep can be most efficient and restful for older adults when nighttime bedroom ambient temperature ranges between 68 to 77 °F. The authors observed an overall trend: a 5-10 % drop in sleep efficiency as the nighttime ambient temperature increases from 77°F to 86°F. Importantly, this research also reveals substantial between-individual differences in optimal bedroom temperature. “These results highlight the potential to enhance sleep quality in older adults by optimizing home thermal environments and emphasizing the importance ...

New study reveals anti-cancer properties in Kencur ginger

2023-08-28

You may know it as an aromatic spice to add flavor to your dishes or as a soothing herbal remedy to use for upset stomachs, but researchers from Osaka Metropolitan University have uncovered promising findings that Kencur, a tropical plant in the ginger family native to Southeast Asia, possesses anti-cancer effects. Led by Associate Professor Akiko Kojima of the Graduate School of Human Life and Ecology, the researchers demonstrated that Kencur extract and its main active component, ethyl p-methoxycinnamate (EMC), significantly suppressed cancer cell growth at the cellular and animal levels. While previous studies on EMC indicated its anti-cancer potential by decreasing the expression ...

New type of visible-light responsive photocatalyst is efficient, stable and very economical

2023-08-28

A new type of versatile economical photocatalyst that harnesses the visible portion of the sunlight spectrum has been developed by researchers from the University of Johannesburg. It is simple to manufacture. Currently, economical photocatalysts only ‘use’ the UV spectrum of sunlight. The new photocatalyst harnesses about a third of the visible light spectrum. The extremely stable, powder-form three-component photocatalyst is built from graphitic carbon (89% of mass), a modified calixarene (10%) and a niobium-containing MXene (1%). Researchers at the University of Johannesburg have developed a new type of photocatalyst that harnesses the visible ...

Low cost, high efficiency, multiple colors at the same time!

2023-08-28

A research team led by Dr. Jung-dae Kwon from the Department of Energy & Electronic Materials at the Korea Institute of Materials Science(KIMS) has succeeded in realizing the world's first transparent thin-film solar cell on a flexible substrate that exhibits different reflective colours and does not significantly reduce solar cell's efficiency. KIMS is a government-funded research institute under the Ministry of Science and ICT. This is a technology that achieves reflective colour only a single material by periodically incorporating hydrogen into zinc oxide material doped with aluminium, which is a transparent electrode, to induce a refractive index difference. ...

New guidance on take-home naloxone for community overdose responders

2023-08-28

New guidance aimed at helping standardize community overdose response and take-home naloxone kits across Canada is published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230128. The guidance is an important document to optimize the effectiveness of take-home naloxone to save lives. The guidance was developed by a panel of experts, including people with lived experience of drug use and overdose response, front-line and harm-reduction workers, public health professionals, clinicians and academics with expertise in harm reduction across Canada. ...

Indigenous females face disparities in health care in Canada

2023-08-28

Indigenous females living "off reserve" face many disparities in health care access, use and unmet needs, found new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221407. The study included 2902 First Nations, 2345 Métis, 742 Inuit and 74 760 non-Indigenous females of reproductive age (aged 15–55 years) obtained from the Canadian Community Health Survey from 2015 to 2020, including 4 months during the COVID-19 pandemic. "We found that ...

Researcher finds inspiration from spider webs and beetles to harvest fresh water from thin air

2023-08-28

A team of researchers is designing novel systems to capture water vapour in the air and turn it into liquid. University of Waterloo professor Michael Tam and his PhD students Yi Wang and Weinan Zhao have developed sponges or membranes with a large surface area that continually capture moisture from their surrounding environment. Traditionally, fresh water for consumption is collected from rivers, lakes, groundwater, and oceans (with treatment). The current technologies Dr. Tam is developing are inspired by nature to harvest water from alternative sources as the world is facing ...

UEA researchers develop new tool to reduce stroke risk

2023-08-28

Peer reviewed – observational study - humans Researchers at the University of East Anglia have developed a new way of identifying patients at risk of an irregular heartbeat, known as ‘atrial fibrillation’. While not life threatening, the condition increases people’s risk of having a transient ischaemic attack (TIA) or stroke by up to five times. A new study, published today, reveals four specific factors that can predict which patients will have atrial fibrillation. These include older age, higher diastolic blood pressure and problems with both the coordination ...

No evidence grammar school systems are best for the brightest, study of 500,000 pupils reveals

2023-08-28

The UK’s brightest pupils’ chances of getting top GCSE grades are actually lower in grammar schools than in comprehensives, according to a major new piece of research. The study, which was based on test results and other information from all pupils in England, challenges the common belief that high achievers do better in more academic schools. Findings, published in the peer-reviewed journal Educational Review, demonstrate those with the highest scores at age 11 were less likely to achieve ...

C-Path’s PKD outcomes consortium receives BAA Award for project to advance drug development tools for autosomal dominant tubulointerstitial kidney disease

Are cannabis products safe and effective for reducing symptoms in children with cancer?

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: